DENN Denny's | $8.07 -2.2% | 4/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $10.50 -> $9.50 | Low | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 4/26/2024 |
DPZ Domino's Pizza | $499.07 +0.9% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $520.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 4/26/2024 |
EAT Brinker International | $48.87 +1.2% | 4/26/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $45.00 -> $47.00 | Low | View details for Wedbush rating of Brinker International (NYSE:EAT) on 4/26/2024 |
MCD McDonald's | $273.12 -0.9% | 4/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $330.00 -> $300.00 | Low | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 4/26/2024 |
SBUX Starbucks | $88.25 +0.5% | 4/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $95.00 -> $92.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 4/26/2024 |
WEN Wendy's | $20.14 +1.6% | 4/26/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $19.00 -> $20.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 4/26/2024 |
|
WING Wingstop | $382.56 +3.4% | 4/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $340.00 -> $400.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 4/26/2024 |
CHKP Check Point Software Technologies | $151.20 -1.1% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $185.00 | Low | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 4/26/2024 |
ROKU Roku | $56.35 -10.3% | 4/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $80.00 -> $75.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 4/26/2024 |
INTC Intel | $31.88 -9.2% | 4/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $40.00 -> $32.50 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/26/2024 |
IMAX IMAX | $17.14 -1.8% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/26/2024 |
BPMC Blueprint Medicines | $93.00 +2.5% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $110.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 4/26/2024 |
SKX Skechers U.S.A. | $65.39 +11.2% | 4/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $68.00 -> $76.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 4/26/2024 |
WDC Western Digital | $71.36 +2.8% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 4/26/2024 |
PEGA Pegasystems | $61.80 +4.6% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 4/26/2024 |
CFR Cullen/Frost Bankers | $107.05 -3.3% | 4/26/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 | Low | View details for Wedbush rating of Cullen/Frost Bankers (NYSE:CFR) on 4/26/2024 |
CUBI Customers Bancorp | $46.82 -5.5% | 4/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $63.00 -> $61.00 | Low | View details for Wedbush rating of Customers Bancorp (NYSE:CUBI) on 4/26/2024 |
VLY Valley National Bancorp | $7.32 -5.8% | 4/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $9.00 -> $8.00 | Low | View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 4/26/2024 |
FFWM First Foundation | $6.08 -9.3% | 4/26/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $8.00 -> $7.00 | Low | View details for Wedbush rating of First Foundation (NASDAQ:FFWM) on 4/26/2024 |
COLB Columbia Banking System | $19.12 +0.6% | 4/26/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 | Low | View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 4/26/2024 |
GOOGL Alphabet | $171.95 +10.2% | 4/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $175.00 -> $205.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/26/2024 |
MSFT Microsoft | $406.32 +1.8% | 4/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $500.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/26/2024 |
SNBR Sleep Number | $14.18 -0.4% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.50 | Low | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 4/25/2024 |
DBD Diebold Nixdorf | $32.05 -0.8% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 4/25/2024 |
ALIT Alight | $9.11
| 4/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 4/25/2024 |
FUBO fuboTV | $1.39 +1.5% | 4/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 4/25/2024 |
CNK Cinemark | $17.65 +1.0% | 4/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $23.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 4/25/2024 |
SLM SLM | $21.90 -0.1% | 4/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $26.00 -> $28.00 | Low | View details for Wedbush rating of SLM (NASDAQ:SLM) on 4/25/2024 |
PPBI Pacific Premier Bancorp | $21.98 -0.8% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $25.00 | Low | View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 4/25/2024 |
COOP Mr. Cooper Group | $78.73 0.0% | 4/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $85.00 -> $100.00 | Low | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 4/25/2024 |
PFSI PennyMac Financial Services | $87.01 +0.9% | 4/25/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $110.00 | Low | View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 4/25/2024 |
BIIB Biogen | $208.90 +3.2% | 4/25/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $213.00 -> $215.00 | Low | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/25/2024 |
CCS Century Communities | $78.82 +0.6% | 4/25/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Underperform -> Underperform | $82.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 4/25/2024 |
IBM International Business Machines | $167.20 -1.0% | 4/25/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $140.00 -> $160.00 | Low | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 4/25/2024 |
CVBF CVB Financial | $16.48 -0.2% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $19.00 | Low | View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 4/25/2024 |
MTH Meritage Homes | $169.48 +2.7% | 4/25/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Underperform -> Underperform | $148.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 4/25/2024 |
TPH Tri Pointe Homes | $37.87 +2.9% | 4/25/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $35.00 | Low | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 4/25/2024 |
ORLY O'Reilly Automotive | $1,043.93 -1.0% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $1,100.00 | Low | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 4/25/2024 |
CVNA Carvana | $84.35 +8.8% | 4/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $60.00 -> $80.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 4/25/2024 |
META Meta Platforms | $443.29 +0.4% | 4/25/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $570.00 -> $480.00 | N/A | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here |
CMG Chipotle Mexican Grill | $3,189.40 +2.5% | 4/25/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,850.00 -> $3,200.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
FR First Industrial Realty Trust | $46.00 -0.1% | 4/25/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $59.00 -> $49.00 | Low | View details for Wedbush rating of First Industrial Realty Trust (NYSE:FR) on 4/25/2024 |
MHO M/I Homes | $120.07 -0.2% | 4/24/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $116.00 -> $130.00 | Low | View details for Wedbush rating of M/I Homes (NYSE:MHO) on 4/24/2024 |
DAWN Day One Biopharmaceuticals | $14.92 +12.9% | 4/24/2024 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024 |
STX Seagate Technology | $86.04 -1.4% | 4/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $100.00 | Low | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
GM General Motors | $45.82 +0.4% | 4/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $55.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 4/24/2024 |
V Visa | $274.58 -0.2% | 4/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $280.00 -> $300.00 | Low | View details for Wedbush rating of Visa (NYSE:V) on 4/24/2024 |
ETSY Etsy | $67.43 +0.3% | 4/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $80.00 -> $70.00 | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 4/24/2024 |
EWBC East West Bancorp | $75.98 -0.5% | 4/24/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 4/24/2024 |
MELI MercadoLibre | $1,406.00 +3.1% | 4/24/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $2,000.00 -> $1,800.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 4/24/2024 |
AMZN Amazon.com | $179.62 +3.4% | 4/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $220.00 -> $225.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 4/24/2024 |
BANC Banc of California | $14.32 +1.6% | 4/24/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $16.00 -> $15.00 | Low | View details for Wedbush rating of Banc of California (NYSE:BANC) on 4/24/2024 |
HAFC Hanmi Financial | $15.82 +1.2% | 4/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $17.00 | Low | View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 4/24/2024 |
ARE Alexandria Real Estate Equities | $116.23 -0.9% | 4/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 | Low | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 4/24/2024 |
SMCI Super Micro Computer | $857.44 +8.9% | 4/24/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $530.00 | Low | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 4/24/2024 |
KNSA Kiniksa Pharmaceuticals | $17.88 +1.5% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform | $30.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/23/2024 |
NTLA Intellia Therapeutics | $20.76 +3.7% | 4/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $29.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 4/23/2024 |
FATE Fate Therapeutics | $3.80 -1.8% | 4/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $7.00 | Low | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 4/23/2024 |
PRME Prime Medicine | $4.43 +2.8% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $12.00 | Low | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 4/23/2024 |
TCRX TScan Therapeutics | $7.32 +0.4% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 4/23/2024 |
VOR Vor Biopharma | $1.69 -0.6% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 4/23/2024 |
ACET Adicet Bio | $1.68 -7.2% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 4/23/2024 |
BEAM Beam Therapeutics | $21.38 -1.0% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $57.00 | Low | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 4/23/2024 |
LOGI Logitech International | $79.26 +0.7% | 4/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 4/23/2024 |
PEP PepsiCo | $175.58 -0.6% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $195.00 | Low | View details for Wedbush rating of PepsiCo (NASDAQ:PEP) on 4/23/2024 |
TSCO Tractor Supply | $273.90 +3.3% | 4/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $235.00 -> $235.00 | Low | View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 4/23/2024 |
CATY Cathay General Bancorp | $35.04 +0.2% | 4/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $44.00 | Low | View details for Wedbush rating of Cathay General Bancorp (NASDAQ:CATY) on 4/23/2024 |
W Wayfair | $52.02 +2.1% | 4/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 4/22/2024 |
REXR Rexford Industrial Realty | $43.20 +0.5% | 4/22/2024 | Initiated by | Wedbush | Analyst R. Anderson | Neutral | $45.00 | Low | View details for Wedbush rating of Rexford Industrial Realty (NYSE:REXR) on 4/22/2024 |
SKX Skechers U.S.A. | $65.39 +11.2% | 4/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $68.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 4/19/2024 |
GPC Genuine Parts | $159.93 -0.7% | 4/19/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $140.00 -> $170.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 4/19/2024 |
BYON Beyond | $21.49 +1.3% | 4/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $43.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 4/19/2024 |
NFLX Netflix | $561.23 -0.6% | 4/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $725.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 4/19/2024 |
ROKU Roku | $56.35 -10.3% | 4/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $120.00 -> $80.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 4/19/2024 |
TSLA Tesla | $168.29 -1.1% | 4/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 4/19/2024 |
WAL Western Alliance Bancorporation | $58.72 +0.2% | 4/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $75.00 -> $70.00 | Low | View details for Wedbush rating of Western Alliance Bancorporation (NYSE:WAL) on 4/19/2024 |
TCBI Texas Capital Bancshares | $57.81 -1.4% | 4/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $64.00 -> $61.00 | Low | View details for Wedbush rating of Texas Capital Bancshares (NASDAQ:TCBI) on 4/19/2024 |
BKNG Booking | $3,521.08 +0.5% | 4/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 4/18/2024 |
ABNB Airbnb | $164.23 +0.7% | 4/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $160.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 4/18/2024 |
EXPE Expedia Group | $135.70 -0.4% | 4/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 4/18/2024 |
YOU Clear Secure | $17.54 +2.0% | 4/18/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $23.00 -> $21.00 | Low | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 4/18/2024 |
TRIP Tripadvisor | $27.45 +4.6% | 4/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $30.00 | Low | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 4/18/2024 |
ARGX argenx | $372.80 +1.1% | 4/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $521.00 | Low | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 4/18/2024 |
DHI D.R. Horton | $145.30 +0.8% | 4/18/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Underperform -> Underperform | $130.00 | Low | View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 4/18/2024 |
IMAX IMAX | $17.14 -1.8% | 4/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/18/2024 |
AMC AMC Entertainment | $3.41 +4.0% | 4/18/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $6.00 -> $4.00 | Low | View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 4/18/2024 |
WTFC Wintrust Financial | $99.01 -0.2% | 4/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $116.00 | Low | View details for Wedbush rating of Wintrust Financial (NASDAQ:WTFC) on 4/18/2024 |
CFG Citizens Financial Group | $35.14 +0.4% | 4/18/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $38.00 -> $35.00 | Low | View details for Wedbush rating of Citizens Financial Group (NYSE:CFG) on 4/18/2024 |
CNK Cinemark | $17.65 +1.0% | 4/18/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $20.00 -> $23.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 4/18/2024 |
SNBR Sleep Number | $14.18 -0.4% | 4/17/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.50 | Low | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 4/17/2024 |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here |
TTWO Take-Two Interactive Software | $144.47 +0.7% | 4/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $190.00 | Low | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 4/17/2024 |
INTC Intel | $31.88 -9.2% | 4/17/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/17/2024 |
AMD Advanced Micro Devices | $157.40 +2.4% | 4/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 | Low | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 4/17/2024 |
APLS Apellis Pharmaceuticals | $49.86 +4.0% | 4/17/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $67.00 -> $57.00 | N/A | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/17/2024 |
ARDX Ardelyx | $6.42 +1.7% | 4/17/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $14.00 | N/A | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 4/17/2024 |
BIIB Biogen | $208.90 +3.2% | 4/17/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $245.00 -> $213.00 | N/A | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 4/17/2024 |
NBIX Neurocrine Biosciences | $135.99 -1.3% | 4/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $147.00 | N/A | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/17/2024 |
SAGE Sage Therapeutics | $13.69 +0.8% | 4/17/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $24.00 | N/A | View details for Wedbush rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024 |
TVTX Travere Therapeutics | $5.26 -2.4% | 4/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | N/A | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 4/17/2024 |
TCRX TScan Therapeutics | $7.32 +0.4% | 4/17/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 4/17/2024 |
KMX CarMax | $69.59 +0.5% | 4/16/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/16/2024 |
EWTX Edgewise Therapeutics | $16.17 +1.4% | 4/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $26.00 | Low | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 4/16/2024 |
RARE Ultragenyx Pharmaceutical | $44.24 +0.9% | 4/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $48.00 | Low | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/16/2024 |
CAVA CAVA Group | $69.13 +10.4% | 4/16/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $65.00 -> $74.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 4/16/2024 |
PVH PVH | $111.03 +0.2% | 4/15/2024 | Upgraded by | Wedbush | Analyst T. Nikic | Neutral -> Outperform | $113.00 -> $128.00 | Low | View details for Wedbush rating of PVH (NYSE:PVH) on 4/15/2024 |
RLYB Rallybio | $1.70 +3.0% | 4/11/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $13.00 -> $11.00 | Low | View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 4/11/2024 |
CGNT Cognyte Software | $6.90 +0.6% | 4/11/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $5.00 -> $8.00 | Low | View details for Wedbush rating of Cognyte Software (NASDAQ:CGNT) on 4/11/2024 |
APP AppLovin | $73.82 +6.7% | 4/11/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $67.00 -> $87.00 | Low | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 4/11/2024 |
ALPN Alpine Immune Sciences | $64.56 -0.1% | 4/11/2024 | Downgraded by | Wedbush | Analyst R. Driscoll | Outperform -> Neutral | | Low | View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024 |
WD Walker & Dunlop | $93.10 +1.1% | 4/11/2024 | Downgraded by | Wedbush | - | Outperform -> Neutral | $130.00 -> $95.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 4/11/2024 |
AIRC Apartment Income REIT | $38.42 -0.1% | 4/11/2024 | Reiterated by | Wedbush | - | Outperform -> Neutral | $35.00 -> $39.00 | Low | View details for Wedbush rating of Apartment Income REIT (NYSE:AIRC) on 4/11/2024 |
RWT Redwood Trust | $5.73 +0.9% | 4/11/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $8.00 -> $6.50 | Low | View details for Wedbush rating of Redwood Trust (NYSE:RWT) on 4/11/2024 |
ABR Arbor Realty Trust | $12.83 +2.3% | 4/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $17.00 -> $13.00 | Low | View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 4/11/2024 |
WD Walker & Dunlop | $93.10 +1.1% | 4/10/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $130.00 -> $95.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 4/10/2024 |
AMZN Amazon.com | $179.62 +3.4% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $220.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 4/10/2024 |
BROS Dutch Bros | $28.57 -1.1% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 4/10/2024 |
CHKP Check Point Software Technologies | $151.20 -1.1% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $185.00 | Low | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 4/10/2024 |
DECK Deckers Outdoor | $833.46 +3.3% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1,000.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 4/10/2024 |
DPZ Domino's Pizza | $499.07 +0.9% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $520.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 4/10/2024 |
EPAM EPAM Systems | $237.75 +0.3% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $340.00 | Low | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 4/10/2024 |
FHN First Horizon | $14.81 +0.1% | 4/10/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of First Horizon (NYSE:FHN) on 4/10/2024 |
GERN Geron | $3.79 +6.5% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 4/10/2024 |
IMAX IMAX | $17.14 -1.8% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/10/2024 |
MGPI MGP Ingredients | $80.54 +1.7% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 4/10/2024 |
MSFT Microsoft | $406.32 +1.8% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $500.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/10/2024 |
MTB M&T Bank | $146.38 -0.4% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $170.00 | Low | View details for Wedbush rating of M&T Bank (NYSE:MTB) on 4/10/2024 |
PEGA Pegasystems | $61.80 +4.6% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 4/10/2024 |
SIMO Silicon Motion Technology | $73.35 +0.6% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 4/10/2024 |
STZ Constellation Brands | $260.04 -0.6% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 | Low | View details for Wedbush rating of Constellation Brands (NYSE:STZ) on 4/10/2024 |
TENB Tenable | $45.99 +1.3% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $65.00 | Low | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 4/10/2024 |
TPX Tempur Sealy International | $49.92 +0.1% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $66.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 4/10/2024 |
GOOGL Alphabet | $171.95 +10.2% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $175.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/10/2024 |
CAKE Cheesecake Factory | $35.36 +1.3% | 4/10/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 4/10/2024 |
FHTX Foghorn Therapeutics | $5.49 +5.0% | 4/10/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/10/2024 |
AAPL Apple | $169.30 -0.3% | 4/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 4/9/2024 |
AVTE Aerovate Therapeutics | $21.75 +0.8% | 4/4/2024 | Reiterated by | Wedbush | Analyst L. Chico | Outperform | | Low | View details for Wedbush rating of Aerovate Therapeutics (NASDAQ:AVTE) on 4/4/2024 |
INZY Inozyme Pharma | $4.44 +2.5% | 4/8/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 4/8/2024 |
GEO The GEO Group | $14.88 +0.6% | 4/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $15.00 -> $22.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 4/8/2024 |
CXW CoreCivic | $15.06 +0.6% | 4/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $18.00 -> $19.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 4/8/2024 |
BDTX Black Diamond Therapeutics | $5.89 +15.3% | 4/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $10.00 -> $16.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 4/8/2024 |
What is Medicare Supplement Insurance? (Ad) Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here |
AXTI AXT | $2.97 +2.4% | 4/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 4/8/2024 |
OVID Ovid Therapeutics | $3.10 +3.7% | 4/5/2024 | Initiated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Ovid Therapeutics (NASDAQ:OVID) on 4/5/2024 |
GOSS Gossamer Bio | $0.67
| 4/5/2024 | Initiated by | Wedbush | - | Outperform | $4.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 4/5/2024 |
TXRH Texas Roadhouse | $157.46 +0.4% | 4/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $170.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 4/5/2024 |
STRO Sutro Biopharma | $3.42
| 4/3/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 4/3/2024 |
HBI Hanesbrands | $4.48 +0.2% | 4/3/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $4.50 -> $5.00 | Low | View details for Wedbush rating of Hanesbrands (NYSE:HBI) on 4/3/2024 |
PAYX Paychex | $119.97 -1.6% | 4/3/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 | Low | View details for Wedbush rating of Paychex (NASDAQ:PAYX) on 4/3/2024 |
INTC Intel | $31.88 -9.2% | 4/3/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 4/3/2024 |
BROS Dutch Bros | $28.57 -1.1% | 4/3/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 4/3/2024 |
KNSA Kiniksa Pharmaceuticals | $17.88 +1.5% | 4/2/2024 | Reiterated by | Wedbush | - | Outperform | $28.00 -> $30.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/2/2024 |
KMX CarMax | $69.59 +0.5% | 4/2/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 -> $100.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/2/2024 |
PRME Prime Medicine | $4.43 +2.8% | 4/2/2024 | Initiated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 4/2/2024 |
DHI D.R. Horton | $145.30 +0.8% | 4/2/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Underperform | $130.00 | Low | View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 4/2/2024 |
MTH Meritage Homes | $169.48 +2.7% | 4/2/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Underperform | $155.00 -> $148.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 4/2/2024 |
CCS Century Communities | $78.82 +0.6% | 4/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Underperform | $92.00 -> $82.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 4/2/2024 |
LEN Lennar | $154.18 +0.9% | 4/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Underperform | $144.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 4/2/2024 |
LGIH LGI Homes | $95.85 +1.0% | 4/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Underperform | $88.00 -> $74.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 4/2/2024 |
IRON Disc Medicine | $27.55 +3.9% | 4/1/2024 | Reiterated by | Wedbush | - | Outperform | $84.00 -> $43.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 4/1/2024 |
IMNM Immunome | $13.73 -3.7% | 4/1/2024 | Target Raised by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $27.00 -> $33.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 4/1/2024 |
HD Home Depot | $335.01 +0.9% | 4/1/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $380.00 -> $410.00 | Low | View details for Wedbush rating of Home Depot (NYSE:HD) on 4/1/2024 |
ASO Academy Sports and Outdoors | $60.72 +2.8% | 4/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $80.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 4/1/2024 |
TSLA Tesla | $168.29 -1.1% | 3/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $315.00 -> $300.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/28/2024 |
RH RH | $249.02 +2.3% | 3/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $275.00 -> $320.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/28/2024 |
TRNO Terreno Realty | $54.13 -0.6% | 3/28/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $67.00 | Low | View details for Wedbush rating of Terreno Realty (NYSE:TRNO) on 3/28/2024 |
GPRO GoPro | $1.73 +1.2% | 3/27/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral | $2.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 3/27/2024 |
NVCR NovoCure | $12.64 +3.3% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral | $21.00 | Low | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
STKS ONE Group Hospitality | $5.21 +1.8% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/27/2024 |
NFLX Netflix | $561.23 -0.6% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $615.00 -> $725.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 3/27/2024 |
APRE Aprea Therapeutics | $5.20 -2.8% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $9.00 -> $11.00 | Low | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 3/27/2024 |
NKE NIKE | $94.11 +0.2% | 3/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/27/2024 |
GME GameStop | $11.90 +6.2% | 3/27/2024 | Target Lowered by | Wedbush | - | Underperform -> Underperform | $6.00 -> $5.60 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/27/2024 |
STOK Stoke Therapeutics | $12.41 +6.2% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $17.00 | Low | View details for Wedbush rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
STRO Sutro Biopharma | $3.42
| 3/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $12.00 -> $8.00 | Low | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
ATXS Astria Therapeutics | $9.00 -1.9% | 3/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/26/2024 |
MSFT Microsoft | $406.32 +1.8% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $475.00 -> $500.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/26/2024 |
WLDN Willdan Group | $28.30 +3.2% | 3/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/25/2024 |
UMH UMH Properties | $15.66 +0.2% | 3/25/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral | $17.00 | Low | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 3/25/2024 |
CMPX Compass Therapeutics | $1.45 -2.0% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 3/22/2024 |
DNTH Dianthus Therapeutics | $21.50 +2.4% | 3/22/2024 | Target Raised by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $24.00 -> $33.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/22/2024 |
DRI Darden Restaurants | $156.10 -0.3% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $187.00 -> $181.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
MGPI MGP Ingredients | $80.54 +1.7% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 3/22/2024 |
ASO Academy Sports and Outdoors | $60.72 +2.8% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $80.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/22/2024 |
RH RH | $249.02 +2.3% | 3/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $275.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/22/2024 |
GOOGL Alphabet | $171.95 +10.2% | 3/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 3/22/2024 |
LULU Lululemon Athletica | $364.70 +1.3% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $548.00 -> $492.00 | Low | View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
CMG Chipotle Mexican Grill | $3,189.40 +2.5% | 3/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,400.00 -> $2,850.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 3/22/2024 |
IRON Disc Medicine | $27.55 +3.9% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform | $79.00 -> $84.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 3/21/2024 |
WSM Williams-Sonoma | $282.16 +0.2% | 3/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $330.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/21/2024 |
GEO The GEO Group | $14.88 +0.6% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/21/2024 |
CXW CoreCivic | $15.06 +0.6% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 3/21/2024 |
My top 100 stocks… (Ad) We recently ran an internal audit of every trade recommendation I’ve published across all my services…
And let me tell ya, we found some incredible insights…
For starters, we found about 100 stocks I trade really, really well. Get some cool freebies right here. |
MU Micron Technology | $114.84 +2.9% | 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $103.00 -> $130.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/21/2024 |
AAPL Apple | $169.30 -0.3% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/21/2024 |
ALIT Alight | $9.11
| 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $14.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 3/21/2024 |
TYRA Tyra Biosciences | $15.67 +3.7% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 | Low | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/21/2024 |
KBH KB Home | $65.60 +2.1% | 3/21/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $60.00 -> $64.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 3/21/2024 |
VOR Vor Biopharma | $1.69 -0.6% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
CHWY Chewy | $15.84 +3.0% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $25.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/21/2024 |
VERA Vera Therapeutics | $39.65 +2.5% | 3/21/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $21.00 -> $34.00 | Low | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 3/21/2024 |
ACET Adicet Bio | $1.68 -7.2% | 3/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024 |
SDHC Smith Douglas Homes | $27.23 +5.4% | 3/20/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $23.00 | Low | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 3/20/2024 |
DSGN Design Therapeutics | $3.78 +0.5% | 3/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of Design Therapeutics (NASDAQ:DSGN) on 3/20/2024 |
FUSN Fusion Pharmaceuticals | $21.42 +0.1% | 3/19/2024 | Downgraded by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $24.00 | N/A | View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024 |
BLUE bluebird bio | $0.92 +1.1% | 3/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.72 -> $1.68 | Low | View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 3/19/2024 |
ALPN Alpine Immune Sciences | $64.56 -0.1% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $47.00 | Low | View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
LEGH Legacy Housing | $20.30 +1.1% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $31.00 -> $25.00 | Low | View details for Wedbush rating of Legacy Housing (NASDAQ:LEGH) on 3/19/2024 |
NCMI National CineMedia | $4.47 -2.6% | 3/19/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $4.50 -> $5.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/19/2024 |
NVDA NVIDIA | $877.35 +6.2% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1,000.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 3/19/2024 |
NKE NIKE | $94.11 +0.2% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $131.00 -> $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/19/2024 |
LEN Lennar | $154.18 +0.9% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 -> $144.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/18/2024 |
TNGX Tango Therapeutics | $7.44 +1.5% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $18.00 | Low | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 3/18/2024 |
LOGI Logitech International | $79.26 +0.7% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral | $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/18/2024 |
TSLA Tesla | $168.29 -1.1% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/13/2024 |
MLTX MoonLake Immunotherapeutics | $42.49 +0.6% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $19.72 +2.4% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $32.00 | Low | View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
PRPL Purple Innovation | $1.52 +0.7% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1.25 -> $2.25 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/13/2024 |
BIRD Allbirds | $0.61
| 3/13/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.00 -> $0.90 | Low | View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 3/13/2024 |
TPX Tempur Sealy International | $49.92 +0.1% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $66.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 3/13/2024 |
INFY Infosys | $16.95 -0.4% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of Infosys (NYSE:INFY) on 3/13/2024 |
DRI Darden Restaurants | $156.10 -0.3% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/15/2024 |
PGY Pagaya Technologies | $10.40 +7.3% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $18.00 -> $11.50 | Low | View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 3/15/2024 |
GERN Geron | $3.79 +6.5% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 3/15/2024 |
DECK Deckers Outdoor | $833.46 +3.3% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $895.00 -> $1,000.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 3/15/2024 |
RMBL RumbleOn | $4.88 -1.6% | 3/15/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $7.50 -> $7.00 | Low | View details for Wedbush rating of RumbleOn (NASDAQ:RMBL) on 3/15/2024 |
DKS DICK'S Sporting Goods | $207.12 +1.4% | 3/15/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $160.00 -> $210.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/15/2024 |
SKLZ Skillz | $6.10 -2.2% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/15/2024 |
GETY Getty Images | $3.92 +0.5% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/15/2024 |
STKS ONE Group Hospitality | $5.21 +1.8% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $6.00 -> $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/15/2024 |
NHI National Health Investors | $62.89 +0.4% | 3/18/2024 | Target Raised by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/18/2024 |
TSVT 2seventy bio | $4.26 -0.9% | 3/18/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 3/18/2024 |
FENC Fennec Pharmaceuticals | $9.21 +0.5% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 | Low | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/18/2024 |
HEAR Turtle Beach | $14.14 +0.6% | 3/14/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/14/2024 |
S SentinelOne | $21.56 +1.7% | 3/14/2024 | Target Raised by | Wedbush | - | Overweight -> Overweight | $28.00 -> $32.00 | Low | View details for Wedbush rating of SentinelOne (NYSE:S) on 3/14/2024 |
JACK Jack in the Box | $58.79 +0.6% | 3/14/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $79.00 -> $88.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 3/14/2024 |
CLSD Clearside Biomedical | $1.34 +6.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of Clearside Biomedical (NASDAQ:CLSD) on 3/13/2024 |
BDTX Black Diamond Therapeutics | $5.89 +15.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/13/2024 |
GEO The GEO Group | $14.88 +0.6% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/13/2024 |
NCMI National CineMedia | $4.47 -2.6% | 3/12/2024 | Reiterated by | Wedbush | - | Neutral | $4.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/12/2024 |
INZY Inozyme Pharma | $4.44 +2.5% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/12/2024 |
IKNA Ikena Oncology | $1.30 -0.8% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 3/12/2024 |
MU Micron Technology | $114.84 +2.9% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 -> $103.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/12/2024 |
ANAB AnaptysBio | $21.00 +11.3% | 3/12/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $20.00 -> $34.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 3/12/2024 |
JANX Janux Therapeutics | $47.39 +0.6% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 3/11/2024 |
SPRY ARS Pharmaceuticals | $8.35 +3.2% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/11/2024 |
PLTR Palantir Technologies | $22.52 +3.7% | 3/8/2024 | Reiterated by | Wedbush | - | Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 3/8/2024 |
PEPG PepGen | $11.93 +2.0% | 3/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $21.00 -> $20.00 | Low | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 3/7/2024 |
ELEV Elevation Oncology | $3.62 -0.5% | 3/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $8.00 | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
GBIO Generation Bio | $2.90 -3.7% | 3/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/7/2024 |
WSM Williams-Sonoma | $282.16 +0.2% | 3/7/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $230.00 -> $280.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/7/2024 |
NYCB New York Community Bancorp | $2.96 -3.6% | 3/7/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.50 -> $3.00 | N/A | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/7/2024 |
SOFI SoFi Technologies | $7.87 +3.7% | 3/6/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.00 | Low | View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 3/6/2024 |